Insider Shareholders with Direct Ownership of Black Diamond Therapeutics, Inc. (BDTX)
This section provides a comprehensive overview of the insiders with direct ownership of Black Diamond Therapeutics, Inc. (BDTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Black Diamond Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 0 | 2,070,889 | 3,726,341 $6 Million | 27 |
Aug 28, 2024
Reduced 5.61%
|
|
|
Growth N V Biotech
> 10% Shareholder |
4,781,993 | 5,784,292 | 2,733,547 $4.4 Million | 16 |
Mar 19, 2025
Reduced 15.46%
|
| 14,500 | 73,000 | 671,423 $1.08 Million | 10 |
Jun 27, 2023
Reduced 3.59%
|
|
|
Elizabeth Buck
CHIEF SCIENTIFIC OFFICER |
75,000 | 0 | 170,192 $274,009 | 1 |
Jan 30, 2025
Added 30.59%
|
| 81,363 | 0 | 125,389 $201,876 | 3 |
Dec 22, 2022
Added 22.48%
|
|
|
Mark A. Velleca
PRESIDENT & CEO |
121,522 | 0 | 121,522 $195,650 | 8 |
Jan 30, 2025
Added 38.16%
|
| 85,150 | 0 | 85,150 $137,091 | 3 |
Jan 30, 2025
Added 46.83%
|
|
| 120,524 | 40,124 | 83,400 $134,274 | 18 |
Jan 30, 2025
Added 47.35%
|
|
|
Sergey Yurasov
CHIEF MEDICAL OFFICER |
75,000 | 0 | 75,000 $120,750 | 1 |
Jan 30, 2025
Added 50.0%
|
| 70,980 | 0 | 70,980 $114,277 | 17 |
Mar 21, 2025
Added 9.72%
|
|
| 42,854 | 0 | 42,854 $68,994 | 10 |
Dec 16, 2022
Added 17.95%
|
|
| 37,168 | 0 | 38,054 $61,266 | 8 |
Mar 15, 2024
Added 7.88%
|
|
|
Bradley J Ph D Bolzon
Director |
13,144 | 0 | 21,851 $35,180 | 6 |
Dec 14, 2020
Added 0.05%
|
| 16,993 | 0 | 16,993 $27,358 | 4 |
Mar 21, 2025
Added 28.72%
|
|
| 8,865 | 0 | 8,865 $14,272 | 3 |
Dec 13, 2024
Added 33.67%
|
|
|
Christopher D. Roberts
Chief Scientific Officer |
28,200 | 25,000 | 3,200 $5,152 | 19 |
May 03, 2021
Reduced 43.86%
|
|
Thomas Leggett
Chief Financial Officer |
12,000 | 12,000 | 0 $0 | 8 |
Jan 08, 2021
Reduced 100.0%
|
| 443 | 443 | 0 $0 | 2 |
May 20, 2021
Reduced 100.0%
|